Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Consider, approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Limited has informed BSE that a meeting of its Board of Directors is scheduled to be held on Friday, 14 November 2025 at 3:30 PM at the company's registered office in Kala Amb, Himachal Pradesh. The main agenda of the meeting is to consider, approve and take on record the Unaudited Standalone Financial Results of the company for the quarter and half year ended 30 September 2025, along with the Limited Review Report. The results will be filed in line with Regulation 33 of the SEBI Listing Regulations. The intimation has been made under Regulation 29(1) of the SEBI Listing Regulations, 2015. The notice is signed by Director Davender Singh (DIN: 09447213).
Investors should watch for the Q2 and H1 FY26 earnings release following the board meeting on 14 November 2025, as the unaudited financial results could influence short-term stock sentiment.